Impact of Anti-CD20 Antibodies on the Incidence of Secondary Cancers in Patients Treated for Chronic Lymphocytic Leukemia

被引：0
|
作者：
Guidez, Stephanie [1 ]
Demarquette, Helene [1 ]
Nudel, Morgane [1 ]
Le Grand, Charline [2 ]
Boyle, Eileen [1 ]
Herbaux, Charles [1 ]
Facon, Thierry [1 ]
Cazin, Bruno [1 ]
Morschhauser, Franck [1 ]
机构：
[1] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France
[2] CHRU Lille, Hop Claude Huriez, F-59037 Lille, France
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Previously Untreated Chronic Lymphocytic Leukemia
    Shah, Arpita
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (10) : 1356 - 1361
  • [22] Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)
    Elias, Shlomo
    Kahlon, Shira
    Kotzur, Rebecca
    Kaynan, Noah
    Mandelboim, Ofer
    ONCOIMMUNOLOGY, 2018, 7 (06):
  • [23] Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for Treatment of Refractory Chronic Lymphocytic Leukemia
    Nightingale, Ginah
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (10) : 1248 - 1255
  • [24] Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy
    Hooley, Ian J.
    Chen, Robert
    Maignan, Kathleen
    Carson, Kenneth R.
    BLOOD, 2018, 132
  • [25] Loss of CD20 expression following treatment with anti-CD20 monoclonal antibody in chronic lymphocytic leukemia.
    Savage, KJ
    Weng, AP
    Kutok, JL
    Pinkus, G
    Gribben, JG
    BLOOD, 2002, 100 (11) : 364B - 364B
  • [26] Comparative Safety Analysis of Currently Approved Anti-CD20 Monoclonal Antibodies for First Line Treatment of Chronic Lymphocytic Leukemia (CLL)
    Mwamburi, Mkaya
    Bal, Vasudha
    Cascella, Teresa
    Shah, Anshul
    Nanavaty, Merena
    Gala, Smeet
    BLOOD, 2016, 128 (22)
  • [27] Comparative safety analysis of currently approved anti-CD20 monoclonal antibodies for first line treatment of chronic lymphocytic leukemia (CLL)
    Gala, Smeet
    Mwamburi, Mkaya
    Bal, Vasudha
    Cascella, Teresa
    Shah, Anshul
    Nanavaty, Merena
    LEUKEMIA & LYMPHOMA, 2017, 58 : 21 - 22
  • [28] Anti-CD20 monoclonal antibody dependent phagocytosis of chronic lymphocytic leukemia cells by autologous macrophages
    Zent, Clive
    Church, Amy
    VanDerMeid, Karl
    Baig, Nisar
    Baran, Andrea
    Witzig, Thomas
    Nowakowski, Grzegorz
    LEUKEMIA & LYMPHOMA, 2015, 56 : 166 - 166
  • [29] Ofatumumab: a novel, fully human anti-CD20 monoclonal antibody for the treatment of chronic lymphocytic leukemia
    Barth, Matthew J.
    Czuczman, Myron S.
    FUTURE ONCOLOGY, 2013, 9 (12) : 1829 - 1839
  • [30] Anti-CD37 antibodies for chronic lymphocytic leukemia
    Robak, Tadeusz
    Robak, Pawel
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 651 - 661
12345